LEADER 01749nam  2200349   450 
001 9910688489603321
005 20230624013840.0
035   $a(CKB)5400000000040392
035   $a(NjHacI)995400000000040392
035   $a(EXLCZ)995400000000040392
100   $a20230624d2014      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aSoft Tissue and Bone Sarcoma /$fedited by Edwin Choy
210  1$aBasel :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2014.
215   $a1 online resource (156 pages) $cillustrations
311   $a3-906980-58-8 
320   $aIncludes bibliographical references.
330   $aSoft tissue and bone sarcomas disproportionately affect children, adolescents, and young adults. Although considered a rare disease, sarcomas continue to have a devastating effect on these patients and their loved ones, and their impact on our society far exceed their relatively low prevalence. Because of its rarity and heterogeneity, clinical decision making on management of sarcomas are often individualized and without a consensus treatment strategy. Furthermore, research to improve clinical outcomes are particularly challenging as sizeable studies are hard to produce. By improving our knowledge about the molecular biology of sarcomas, we hope to identify new treatment strategies and targets for further drug development.
606   $aConnective tissues
615  0$aConnective tissues.
676   $a599.0
702   $aChoy$b Edwin
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688489603321
996   $aSoft Tissue and Bone Sarcoma$91804364
997   $aUNINA